Why the study?
Does postinfection treatment with antiviral serum prevent death in human neuroblastoma cells infected with virulent poliovirus?
Does postinfection treatment with antiviral serum prevent death in human neuroblastoma cells infected with virulent poliovirus?
Antiserum treatment of poliovirus-infected neuroblastoma cells prevents cell death and allows for the development of postinfection immunity.
No change to poliovirus management; leaves open antiserum effects on immunity in human neuronal models.
The death of human neuroblastoma cells undergoing productive infection with virulent poliovirus was prevented by addition of antiserum against the virus a few hours after the onset of infection; this treatment, however, did not prevent reproduction of the virus. Despite the presence of the viral antigen, the cells retained the ability to divide. Upon further cultivation in the absence of antiserum, the cells developed specific postinfection immunity or resistance to superinfection with poliovirus.
No takes yet. Share an insight, caveat, or question.
Tolskaya et al. (1992) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: